Enumeral Biomedical Holdings, Inc. (OTCQB: ENUM), announced today it appointed Paul J. Sekhri to its Board of Directors. Mr. Sekhri is an accomplished industry executive, with more than 25 years of experience in life sciences strategy, corporate development and corporate finance, having served in senior leadership positions at several pharmaceutical companies, including Novartis, Teva and Sanofi. He is currently President and Chief Executive Officer of Lycera, and he also serves on its board of directors.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
